Table 2.
Characteristic | All (n = 94) | Successful Therapeutic Bronchoscopy (n = 50) | Unsuccessful Therapeutic Bronchoscopy (n = 44) | p value |
---|---|---|---|---|
Tumor Origin | 0.771 | |||
Lung | 67 (71.3) | 35 (70.0) | 32 (72.7) | |
Metastatic (from other areas) | 27 (28.7) | 15 (30.0) | 12 (27.3) | |
Tumor Histology | 0.203 | |||
NSCLC | 54 (57.4) | 26 (52.0) | 28 (63.6) | |
SCLC | 6 (6.4) | 2 (4.0) | 4 (9.1) | |
Breast | 2 (2.1) | – | 2 (4.5) | |
Carcinoid | 7 (7.4) | 7 (14.0) | – | |
Gastrointestinal | 6 (6.4) | 3 (6.0) | 3 (6.8) | |
Lymphoma | 1 (1.1) | 1 (2.0) | – | |
Melanoma | 1 (1.1) | 1 (2.0) | – | |
Mesothelioma | 1 (1.1) | – | 1 (2.3) | |
Pheochromocytoma | 1 (1.1) | – | 1 (2.3) | |
Renal | 9 (9.6) | 6 (12.0) | 3 (6.8) | |
Sarcoma | 3 (3.2) | 2 (4.0) | 1 (2.3) | |
Thymoma | 1 (1.1) | 1 (2.0) | – | |
Uterine | 2 (2.1) | 1 (2.0) | 1 (2.3) | |
NSCLC Pathology | 0.232 | |||
Adenocarcinoma | 15 (27.8) | 6 (23.1) | 9 (32.1) | |
Large Cell | 4 (7.4) | 1 (3.8) | 3 (10.7) | |
Poorly Differentiated | 2 (3.7) | – | 2 (7.1) | |
Squamous Cell | 33 (61.1) | 19 (73.1) | 14 (50.0) | |
Obstruction Type | 0.600 | |||
Extrinsic | 10 (10.6) | 6 (12.0) | 4 (9.1) | |
Intrinsic | 68 (72.3) | 34 (68.0) | 34 (77.3) | |
Mixed | 16 (17.0) | 10 (20.0) | 6 (13.6) | |
Mass Location (specific) | 0.068 | |||
Bronchus Intermedius | 14 (14.9) | 6 (12.0) | 8 (18.2) | |
Left Mainstem | 30 (31.9) | 15 (30.0) | 15 (34.1) | |
Lobar | 18 (19.1) | 6 (12.0) | 12 (27.3) | |
Right Mainstem | 25 (26.6) | 17 (34.0) | 8 (18.2) | |
Trachea | 7 (7.4) | 6 (12.0) | 1 (2.3) | |
Mass Location (general) | 0.060 | |||
Lobar | 18 (19.1) | 6 (12.0) | 12 (27.3) | |
Non-Lobar | 76 (80.9) | 44 (88.0) | 32 (72.7) | |
Radiographic Distal Airway Patency | < 0.001* | |||
Yes | 36 (39.6) | 31 (66.0) | 5 (11.4) | |
No | 55 (60.4) | 16 (34.0) | 39 (88.6) | |
Unknown | 3 (−) | 3 (−) | – |
Data shown as number (%); *p < 0.05 compared to unsuccessful therapeutic bronchoscopy group